Other files for this federal contract opportunity
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
The file's text, extracted by GovTribe without its formatting.
Item Description
| Est. Quantities |
| Unit |
| Unit Price |
| Total Price |
| Cryoprecipitated Ahf, Preparation |
| 20 |
| EA |
| Pooled Cryo (Flat Fee) |
| 20 |
| EA |
| Plasma Cryo Depleted, Preparation |
| 0 |
| EA |
| Fresh Frozen Plasma(250ml) |
| 0 |
| EA |
| Fresh Frozen Plasma(250ml), type AB |
| 0 |
| EA |
| FFP Frozen w/i 24 Hours |
| 0 |
| EA |
| FFP Frozen w/i 24 Hours type AB |
| 0 |
| EA |
| Fresh Frozen Plasma(50ml), Prep |
| 100 |
| EA |
| Deglycerolized-Autologous RBC |
| 0 |
| EA |
| Autologous RBC, Frozen |
| 0 |
| EA |
| Red Blood Cells(Auto) Processing |
| 0 |
| EA |
| Resuspended Cells, Processing |
| 0 |
| EA |
| RBC, Leukoreduced, returned AB |
| 0 |
| EA |
| RBC, Leukoreduced, Frozen |
| 0 |
| EA |
| RBC, Leukoreduced, CMV NEG |
| 0 |
| EA |
| RBC, Leukoreduced, Irradiate |
| 1020 |
| EA |
| RBC, Leukoreduced, Irradiate, CMV |
| 0 |
| EA |
| RBC, Leukoreduced, Washed |
| 0 |
| EA |
| RBC, LR, IRR, Washed |
| 0 |
| EA |
| RBC, LR, Frozen, Washed, Deglycerolized |
| 0 |
| EA |
| RBC, LR, IRR, Frozen, Washed, Deglycerolized |
| 0 |
| EA |
| PLATELETS BY APHERESIS DIRECTED |
| 0 |
| EA |
| Platelets by Apheresis LR |
| 120 |
| EA |
| Platelets by Apheresis LR IRRD |
| 530 |
| EA |
| Platelets by Apheresis LR, CMV, IRRD |
| 0 |
| EA |
| GRANULOCYTES BY APHERESIS |
| 0 |
| EA |
| Platelets, Leukocytes Reduced (PSPP) |
| 0 |
| EA |
| Platelets, LR, Irradiated (PSPP) |
| 0 |
| EA |
| Plateletpheresis, LVDS, Irradiated |
| 0 |
| EA |
| Plateletpheresis, PRT |
| 0 |
| EA |
| Hepatitis Test (HBSAG) |
| 120 |
| EA |
| HEP B Surface(HBS) Neutralization |
| 0 |
| EA |
| Hepatitis Test (Anti-HCV) |
| 120 |
| EA |
| HEPATITIS C (HCV) RIBA TEST |
| 0 |
| EA |
| Hepatitis Test (Anti-HBC) |
| 120 |
| EA |
| Serologic Test For Syphilis |
| 120 |
| EA |
| FLOURESCENT TREPONEMAL ANTIBODY TEST FTA |
| 0 |
| EA |
| Anti Cytomegalovirus(CMV) Test |
| 120 |
| EA |
| Chagas Test-Patient |
| 20 |
| EA |
| Chagas Confirmatory Testing |
| 0 |
| EA |
| Anti-HIV 1/2 Antibody Test |
| 100 |
| EA |
| HIV 1/2 Confirmation |
| 0 |
| EA |
| Anti HTLV-1/-2 Test |
| 100 |
| EA |
| Epstein Barr Virus NA-IgG |
| 0 |
| EA |
| Zika Virus by Nucleic Acid Testing |
| 0 |
| EA |
| THERAPEUTIC PLASMA EXCH |
| 30 |
| EA |
| THERAPEUTIC PLATELETPHERESIS |
| 0 |
| EA |
| THERAPEUTIC RED CELL EXCH |
| 0 |
| EA |
| THERAPEUTIC LEUKAPHERESIS |
| 0 |
| EA |
| Red Cell Genotyping for Single Antigen |
| 0 |
| EA |
| Rh Genotyping - Multiplex (D,C) |
| 0 |
| EA |
| Red Cell Genotyping for MNS |
| 0 |
| EA |
| Red Cell Genotyping Multiple Groups |
| 0 |
| EA |
| Rhd Zygosity inc CDE Systems |
| 0 |
| EA |
| ABO Blood Groups by PCR |
| 0 |
| EA |
| RhD variant - weak D type 1, 2, and 3 |
| 0 |
| EA |
| Factor XIII (By Urea Solubility) |
| 0 |
| EA |
| Factor XIII Quantitative |
| 0 |
| EA |
| VWF Activity by Ristocetin Cofactor |
| 0 |
| EA |
| FDP in plasma (semi quantitative) |
| 0 |
| EA |
| Factor VIII Activity (one stage) |
| 0 |
| EA |
| Factor VIII Activity (Chromogenic) |
| 0 |
| EA |
| Von Willebrand Factor Multimers |
| 40 |
| EA |
| Von Willebrand Collagen Binding |
| 0 |
| EA |
| Factor VIII INHIBITOR TITER-PORCINE |
| 0 |
| EA |
| Staclot-La (Hexagonal Pl) |
| 0 |
| EA |
| Factor IX Inhib Bethesda Human |
| 0 |
| EA |
| Factor II Inhib Bethesda Human |
| 0 |
| EA |
| Factor V Inhib Bethesda Human |
| 0 |
| EA |
| Factor VII Inhib Bethesda Human |
| 0 |
| EA |
| Factor X Inhib Bethesda Human |
| 0 |
| EA |
| Factor XI Inhib Bethesda Human |
| 0 |
| EA |
| Factor VIII Inhibitor Bethesda Titer - Chromogenic |
| 0 |
| EA |
| Platelet Aggregation (9 Agonists) |
| 0 |
| EA |
| Red Cell Separate for Phenotyping |
| 0 |
| EA |
| Platelet Function Assay (PFA) Epine |
| 0 |
| EA |
| Platelet Function Assay (PFA) Adp |
| 0 |
| EA |
| HEMOPHILIA A Mutation Evaluation |
| 0 |
| EA |
| Factor VIII Inversion |
| 0 |
| EA |
| DNA Von Willebrand Disease Type 2A/2B/2M |
| 0 |
| EA |
| DNA Von Willebrand Disease Type 2N |
| 0 |
| EA |
| Hemophilia B Mutation Evaluation |
| 0 |
| EA |
| Genotype for known Hemophilia/VWD mutations |
| 0 |
| EA |
| DECEASED DONOR WORKUP |
| 0 |
| EA |
| DECEASED DONOR WORKUP-IMPORT |
| 0 |
| EA |
| HLA-DQ2/DQ8/DQA1*05 (Celiac association) |
| 0 |
| EA |
| HLA ANTIBODY DETECTION |
| 0 |
| EA |
| HLA Antibody Specificity |
| 0 |
| EA |
| HLA Antibody Specificity Monitoring DSA |
| 40 |
| EA |
| HLA Antibody Specificity Monitoring DSA - STAT |
| 0 |
| EA |
| MIC Antibody Specificity |
| 0 |
| EA |
| C1q fixing HLA Antibody Specificity |
| 0 |
| EA |
| C1q fixing HLA Antibody Monitoring DSA |
| 0 |
| EA |
| HLA CLASS I (A,B, C) TYPING |
| 0 |
| EA |
| HLA CLASS II (DR,DQ) TYPING |
| 0 |
| EA |
| HLA CLASS I & CLASS II (A,B,C,DR,DQ) Typing |
| 0 |
| EA |
| SPECIMEN PROCESSING (SERUM) |
| 0 |
| EA |
| SPECIMEN PROCESSING (CELLS) |
| 0 |
| EA |
| LYMPHOCYTE CROSSMATCH |
| 0 |
| EA |
| LYMPHOCYTE CROSSMATCH - STAT |
| 0 |
| EA |
| LYMPHOCYTE CROSSMATCH -Cytotoxicity |
| 0 |
| EA |
| Platelet Alloantibody Workup (Basic) |
| 0 |
| EA |
| HLA -A2 or A*0201 Typing |
| 0 |
| EA |
| HIGH-RESOLUTION TYPING, HLA-A |
| 0 |
| EA |
| HIGH-RESOLUTION TYPING, HLA-B |
| 0 |
| EA |
| HIGH-RESOLUTION TYPING, HLA-C |
| 0 |
| EA |
| HIGH-RESOLUTION TYPING, HLA-DPA1 |
| 0 |
| EA |
| HIGH-RESOLUTION TYPING, HLA-DPB1 |
| 0 |
| EA |
| HIGH-RESOLUTION TYPING, HLA-DQA1 |
| 0 |
| EA |
| HIGH-RESOLUTION TYPING, HLA-DQB1 |
| 0 |
| EA |
| HIGH-RESOLUTION TYPING, HLA-DRB1 |
| 0 |
| EA |
| High Resolution HLA DRB3/DRB4/DRB5 |
| 0 |
| EA |
| CROSSMATCH ANTIGLOBULIN IRL |
| 0 |
| EA |
| CROSSMATCH ELECTRONIC IRL |
| 0 |
| EA |
| RED CELL ANTIBODY TITRATION |
| 20 |
| EA |
| RH PHENOTYPE (D,C,E,C Antigentype) |
| 20 |
| EA |
| Patient PHENOTYPE Single Antigen |
| 20 |
| EA |
| Screening of compatible RBC units |
| 0 |
| EA |
| Direct Antiglobulin Test Monospecific IRL |
| 20 |
| EA |
| Direct Antiglobulin Test Polyspecific IRL |
| 20 |
| EA |
| Red Cell ANTIBODY PANEL (per panel) |
| 120 |
| EA |
| Red Cell ANTIBODY PANEL (per panel) TSL |
| 20 |
| EA |
| Chemical Treatment Red Cells |
| 70 |
| EA |
| Enzyme Treatment Red Cells |
| 20 |
| EA |
| CHEMICAL TREATMENT SERUM |
| 0 |
| EA |
| PATIENT PHENOTYPE EXTENDED |
| 0 |
| EA |
| AFTER HOURS SURCHARGE |
| 0 |
| EA |
| UNIT PHENOTYPE/ANTIGEN/UNIT |
| 340 |
| EA |
| Rare/Uncommon Unit Search Fee |
| 0 |
| EA |
| Imported Unit Fees - per unit |
| 0 |
| EA |
| Platelet Alloantibody Workup (Advanced) |
| 0 |
| EA |
| Platelet Autoantibody Test |
| 0 |
| EA |
| Platelet Drug Antibody Test |
| 0 |
| EA |
| Hep/PF4 IgG ELISA (HIT) |
| 0 |
| EA |
| Hep/PF4 IgG ELISA Confirmation |
| 0 |
| EA |
| Post-Transfusion Purpura (PTP) Workup |
| 0 |
| EA |
| Neonatal Alloimmune Thrombocytopenia Eval |
| 0 |
| EA |
| Platelet Typing/Single Platelet Antigen |
| 0 |
| EA |
| CROSSMATCH ANTIGLOBULIN |
| 50 |
| EA |
| RETROSPECTIVE XMATCH ANTIGLOBULIN |
| 20 |
| EA |
| Xmatch Immediate Spin |
| 0 |
| EA |
| XMatch Potential Donor ABO Compatible |
| 0 |
| EA |
| XMatch Potential Donor ABO Incompatible |
| 20 |
| EA |
| CROSSMATCH ELECTRONIC |
| 2100 |
| EA |
| RETROSPECTIVE CROSSMATCH ELECTRONIC |
| 50 |
| EA |
| Uncrossmatched Unit Handling fee |
| 0 |
| EA |
| EMERGENCY TESTING OR RELEASE |
| 660 |
| EA |
| Confirmatory 2nd Sample |
| 750 |
| EA |
| INDIRECT ANTIGLOBULIN TEST |
| 2040 |
| EA |
| Patient antigen type - TSL |
| 0 |
| EA |
| HOLD Specimen Charge |
| 40 |
| EA |
| DIRECT ANTIGLOBULIN TEST |
| 40 |
| EA |
| INVESTIGATION OF TRANSFUSION REAC |
| 0 |
| EA |
| Limited Transfusion Reaction Invest |
| 0 |
| EA |
| Irradiated Unit, Preparation |
| 0 |
| EA |
| Reduced Volume, Preparation |
| 100 |
| EA |
| Prep of RBCs, Plasma Reduced |
| 0 |
| EA |
| Preparation of Red Cells, Washed |
| 0 |
| EA |
| Preparation of Platelets, Washed |
| 0 |
| EA |
| Pooling, Resuspended RBC |
| 0 |
| EA |
| Hemosafe/HaemoBank - Site VPN monitoring |
| 12 |
| MO |
| Hemosafe/HaemoBank - Support/Maintenance |
| 12 |
| MO |
| Hemosafe/HaemoBank Software Licensing |
| 12 |
| MO |
| HaemoBank 80 Rental Fee |
| 12 |
| MO |
File details come from the government source that posted it.
Updated .